{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T01:59:59Z","timestamp":1779242399085,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,8]]},"DOI":"10.7759\/cureus.75336","type":"journal-article","created":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T22:26:21Z","timestamp":1733696781000},"source":"Crossref","is-referenced-by-count":1,"title":["Relapsed Multiple Myeloma in the Gastrointestinal Tract With Aberrant Expression of CD3: A Case Report"],"prefix":"10.7759","author":[{"given":"Priscilla","family":"Quach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan M","family":"Ash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark T","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0141","article-title":"Multiple myeloma incidence and mortality around the globe; interrelations between health access and quality, economic resources, and patient empowerment","volume":"25","author":"Ludwig H","year":"2020","unstructured":"Ludwig H, Novis Durie S, Meckl A, Hinke A, Durie B. Multiple myeloma incidence and mortality around the globe; interrelations between health access and quality, economic resources, and patient empowerment. Oncologist. 2020, 25:e1406-13. 10.1634\/theoncologist.2020-0141","journal-title":"Oncologist"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_159009","article-title":"Updated diagnostic criteria and staging system for multiple myeloma","volume":"35","author":"Rajkumar SV","year":"2016","unstructured":"Rajkumar SV. Updated diagnostic criteria and staging system for multiple myeloma. Am Soc Clin Oncol Educ Book. 2016, 35:e418-23. 10.1200\/EDBK_159009","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4816","article-title":"Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts-a follow-up","volume":"11","author":"Holler A","year":"2022","unstructured":"Holler A, Cicha I, Eckstein M, et al.. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts-a follow-up. Cancer Med. 2022, 11:4743-55. 10.1002\/cam4.4816","journal-title":"Cancer Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1761204","article-title":"Immunophenotypic profile of multiple myeloma: a tertiary care centre experience","volume":"15","author":"Rath A","year":"2023","unstructured":"Rath A, Panda T, Dass J, Seth T, Mahapatra M, Tyagi S. Immunophenotypic profile of multiple myeloma: a tertiary care centre experience. J Lab Physicians. 2023, 15:392-8. 10.1055\/s-0043-1761204","journal-title":"J Lab Physicians"},{"key":"ref5","article-title":"Clinical and biological features of multiple myeloma involving the gastrointestinal system","volume":"91","author":"Talamo G","year":"2006","unstructured":"Talamo G, Cavallo F, Zangari M, et al.. Clinical and biological features of multiple myeloma involving the gastrointestinal system. Haematologica. 2006, 91:964-7.","journal-title":"Haematologica"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2008.01087.x","article-title":"Clinicopathological features of extramedullary recurrence\/relapse of multiple myeloma","volume":"81","author":"Cerny J","year":"2008","unstructured":"Cerny J, Fadare O, Hutchinson L, Wang SA. Clinicopathological features of extramedullary recurrence\/relapse of multiple myeloma. Eur J Haematol. 2008, 81:65-9. 10.1111\/j.1600-0609.2008.01087.x","journal-title":"Eur J Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00527-y","article-title":"Extramedullary disease in multiple myeloma","volume":"11","author":"Bansal R","year":"2021","unstructured":"Bansal R, Rakshit S, Kumar S. Extramedullary disease in multiple myeloma. Blood Cancer J. 2021, 11:161. 10.1038\/s41408-021-00527-y","journal-title":"Blood Cancer J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.177","article-title":"CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall","volume":"31","author":"Pan Z","year":"2018","unstructured":"Pan Z, Chen M, Zhang Q, et al.. CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall. Mod Pathol. 2018, 31:718-31. 10.1038\/modpathol.2017.177","journal-title":"Mod Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000348550","article-title":"Incidence and clinical significance of aberrant T-cell marker expression on diffuse large B-cell lymphoma cells","volume":"130","author":"Suzuki Y","year":"2013","unstructured":"Suzuki Y, Yoshida T, Wang G, et al.. Incidence and clinical significance of aberrant T-cell marker expression on diffuse large B-cell lymphoma cells. Acta Haematol. 2013, 130:230-7. 10.1159\/000348550","journal-title":"Acta Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1309\/v8yg-8pp4-b4te-9x6j","article-title":"Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas","volume":"115","author":"Kaleem Z","year":"2001","unstructured":"Kaleem Z, White G, Zutter MM. Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas. Am J Clin Pathol. 2001, 115:396-403. 10.1309\/v8yg-8pp4-b4te-9x6j","journal-title":"Am J Clin Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31825e63a9","article-title":"Clinicopathologic features of B-Cell lineage neoplasms with aberrant expression of CD3: a study of 21 cases","volume":"36","author":"Oliveira JL","year":"2012","unstructured":"Oliveira JL, Grogg KL, Macon WR, Dogan A, Feldman AL. Clinicopathologic features of B-Cell lineage neoplasms with aberrant expression of CD3: a study of 21 cases. Am J Surg Pathol. 2012, 36:1364-70. 10.1097\/PAS.0b013e31825e63a9","journal-title":"Am J Surg Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/309952-relapsed-multiple-myeloma-in-the-gastrointestinal-tract-with-aberrant-expression-of-cd3-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T22:26:23Z","timestamp":1733696783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/309952-relapsed-multiple-myeloma-in-the-gastrointestinal-tract-with-aberrant-expression-of-cd3-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,8]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.75336","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,8]]}}}